drugset / Trial / NCT00555789
24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will provide continued treatment and assess the long term safety, efficacy and tolerability of oral AEB071 plus tacrolimus vs. mycophenolic acid plus tacrolimus after kidney transplantation.
Timeline
- Start
- 2007-10
- Primary completion
- 2008-03
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | mycophenolic acid | Small molecule | 720 mg | — |
| Subject | sotrastaurin | Small molecule | 200 mg | Oral |
| Comparator | Tacrolimus | Small molecule | — | — |
Indications
No indication recorded.